These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11865463)

  • 1. [Therapeutic prospects for subacute transmissible spongiform encephalopathies].
    Seman M; Adjou KT
    Rev Prat; 1999 May; 49(9):971-5. PubMed ID: 11865463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What are the prospects for pharmacological treatment of prion disease?].
    Adjou KT; Seman M
    Therapie; 2002; 57(2):123-7. PubMed ID: 12185959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human spongiform encephalopathies].
    Cathala F
    Pathol Biol (Paris); 1995 Jan; 43(1):6-21. PubMed ID: 7777378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MS-8209, an amphotericin B analogue, delays the appearance of spongiosis, astrogliosis and PrPres accumulation in the brain of scrapie-infected hamsters.
    Adjou KT; Privat N; Demart S; Deslys JP; Seman M; Hauw JJ; Dormont D
    J Comp Pathol; 2000 Jan; 122(1):3-8. PubMed ID: 10627386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutical approaches to transmissible spongiform encephalopathies (TSE): the case of amphotericin-B.
    Calissano M; Petraroli R; Pocchiari M
    J Biol Regul Homeost Agents; 1996; 10(4):69-71. PubMed ID: 9604774
    [No Abstract]   [Full Text] [Related]  

  • 6. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic approaches for treatment of Creutzfeldt-Jakob disease].
    Heinemann U; Weiss S; Zerr I
    Med Monatsschr Pharm; 2008 Oct; 31(10):378-84. PubMed ID: 18972868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.
    Collins SJ; Lewis V; Brazier M; Hill AF; Fletcher A; Masters CL
    Ann Neurol; 2002 Oct; 52(4):503-6. PubMed ID: 12325081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation.
    Hafner-Bratkovic I; Gaspersic J; Smid LM; Bresjanac M; Jerala R
    J Neurochem; 2008 Mar; 104(6):1553-64. PubMed ID: 17996023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
    Todd NV; Morrow J; Doh-ura K; Dealler S; O'Hare S; Farling P; Duddy M; Rainov NG
    J Infect; 2005 Jun; 50(5):394-6. PubMed ID: 15907546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches targeting the prion receptor LRP/LR.
    Zuber C; Ludewigs H; Weiss S
    Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Present perspectives on Creutzfeldt-Jakob disease: pathogenesis, diagnosis and treatment].
    Vargas P; López-Brea M
    Rev Esp Quimioter; 2002 Sep; 15(3):225-32. PubMed ID: 12582425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human transmissible spongiform encephalopathies].
    Leibovitz I; Zamir D; Polychuck I; Kahana E
    Harefuah; 2003 Jan; 142(1):70-3, 76. PubMed ID: 12647494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons.
    Demaimay R; Race R; Chesebro B
    J Virol; 1999 Apr; 73(4):3511-3. PubMed ID: 10074211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
    Bastian FO; Fermin CD
    Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?
    Hartsel SC; Weiland TR
    Biochemistry; 2003 May; 42(20):6228-33. PubMed ID: 12755626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vagus nerve as a conduit for neuroinvasion, a diagnostic tool, and a therapeutic pathway for transmissible spongiform encephalopathies, including variant Creutzfeld Jacob disease.
    Pomfrett CJ; Glover DG; Pollard BJ
    Med Hypotheses; 2007; 68(6):1252-7. PubMed ID: 17166667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.